Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
Department of Human Services
    Quick Reference
For Clinicians
Breast Cancer Resources. Guidelines
Guide/CBE Results
Imaging Result Categories
Special Populations


Algorithms
Palpable mass (> age 40)
Palpable mass (< age 40)
Non-palpable abnormalities

Cervical Cancer Resources.Guidelines
Protocols Overview
Pap Smear Nomenclature
HPV Testing


Algorithms
Cervical Care Algorithm
History of CIN-2/CIN-3
Management of CIN



For Case Managers
Breast Cancer Resources.Guidelines
Diagnostic Workup
Types of Cancer
Staging of Invasive Cancer
Treatment Options

Cervical Cancer Resources.Guidelines
Diagnostic Procedures
Treatment Modalities

For Patients
Where to Get Help

  Quick Reference for Clinicians: Cervical Guidelines

PAP Smear Screening Protocol for the Primary Care Provider

Warning
Colposcopy is indicated for signs or symptoms of cancer, even if the Pap smear is normal.
Need colposcopy when there is a visible lesion or unexplained, persistent vaginal bleeding.
Frequency
Yearly starting at 3 years after the onset of sex (or age 21). After 3 normal annual Paps, then every 3 years.
If any HSIL need Pap smears yearly thereafter, for life.
Not needed after hysterectomy with no cervical stump unless history of HSIL/cancer Pap smears.
Not needed in well screened woman after age 65, if no Paps have been abnormal (HSIL/cancer)
Not necessary in women who have never had any sexual activity. However, lesbian women with only female sexual partners do need Pap smears.
Need for Pap smears depends on woman?s entire lifetime sexual experience (including sexual abuse).
Ideal Preparation
No washing vagina or douching within 48 hours before Pap
Nothing in vagina within 48 hours before Pap - no sexual intercourse, tampons, vaginal contraceptives, medications.
1-2 weeks after menses, about mid-cycle
No bleeding or infection
Eight weeks postpartum if recent pregnancy
Perform speculum pelvic examination without lubrication (except water)
Equipment
Glass slide with frosted end - to make thin smear with identification labeling
Wooden (preferred for slide) or plastic (for liquid-base)
Ayre spatula - samples ectocervix
Endocervical - brush (preferred) turn times; saline moistened swab may be safer if pregnant
Broom - not recommended
Alcohol or similar fixative - liquid for pour-on, pump spray, or immersion better than propellent spray
Order of Specimens - if other tests are taken
Vaginal pH and wet smear - collect first, before contamination with blood or cervical discharge
Pap smear - first instrument to touch cervix as dysplastic cells are often shed in cervical mucus
Gram stain of cervix - collect mucus or pus, examine at least if PID or cervicitis suspected
HPV test - rotate swab, provided in kit, in cervical os for half turns, clockwise and counterclockwise, 3 times each, and swab the transformational zone.
Gonorrhea test - collect mucus or pus
Chlamydia test - scrub to obtain cells
Proper Preparation of Specimen
Don?t clean the cervix first, if excess material or infection, very gently pat cervix, or use two slides
Collect from entire transformation zone - include endocervical sample
Make thin (mono-layer) smear on slide - arch spatula and then roll brush
Fix promptly - avoid air drying
Proper Labeling of Specimen - slide will be rejected if lacks proper identification and history
Name and other identifiers on frosted end of slide and on package
Lab slip with complete identification and clinical information
Laboratory statistics - expected ranges, higher if lab mainly serves high risk (STD, colposcopy, cancer)
Unsatisfactory - 0.2% to 1% (range up to 20%), suspect if none.
Lack endocervical cells/TZ Component - 2% to 10% (range up to 40%). If high ( >5%) improve client preparation and collection technique. Ask lab to review.
ASC-US (Atypical) - 2% to 5% (median 2.9%). If > 9% or double SIL suspect overuse of category.
Ratio of ASC-US/SIL should be under 2 (mean 1.3)
LSIL - 0.5% to 3%. May be higher if high risk population (STD or colposcopy clinic)
HSIL - < 1% (higher if high risk population)
AGC - 0.2% - 1.8%
References:
National Committee for Clinical Laboratory Standards. Papanicolaou Technique; Approved Guideline. Villanova, PA: NCCLS, 1994. (771 East Lancaster Avenue, Villanova, PA, 19085, GP15-A)
USPSTF, Screening for Cervical Cancer: Recommendations and Rationale. Am Fam Physician 2003;67:1759-66.

 
Page updated: September 21, 2007

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.